Filing Details
- Accession Number:
- 0001209191-14-059877
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2014-09-26 11:33:09
- Reporting Period:
- 2014-09-23
- Filing Date:
- 2014-09-26
- Accepted Time:
- 2014-09-26 11:33:09
- Original Submission Date:
- 2014-09-25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1412067 | Oncothyreon Inc. | ONTY | Services-Commercial Physical & Biological Research (8731) | 260868560 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1413350 | Jay Venkatesan | C/O Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA 98121 | Evp And General Manager | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-09-23 | 250,000 | $2.00 | 250,000 | No | 4 | P | Indirect | By Ayer Special Situations Fund I, LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Ayer Special Situations Fund I, LP |
Footnotes
- This amended Form 4 is being filed only to reflect that the shares in this line were "purchased" using code "P" instead of being "acquired" using code "A", which was an inadvertent error. No other changes are reflected in this amended Form 4.
- The securities are held by Ayer Special Situations Fund I, LP ("ASSF"), the investment advisor of which is Ayer Capital Management, LP ("ACM LP"). The reporting person is a managing member of ACM LP, and may be deemed to share voting and investment power over the securities held by ASSF. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.